These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 29028375)

  • 1. Health Disparities in Patients with Pulmonary Arterial Hypertension: A Blueprint for Action. An Official American Thoracic Society Statement.
    Talwar A; Garcia JGN; Tsai H; Moreno M; Lahm T; Zamanian RT; Machado R; Kawut SM; Selej M; Mathai S; D'Anna LH; Sahni S; Rodriquez EJ; Channick R; Fagan K; Gray M; Armstrong J; Rodriguez Lopez J; de Jesus Perez V;
    Am J Respir Crit Care Med; 2017 Oct; 196(8):e32-e47. PubMed ID: 29028375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary Arterial Hypertension in Women.
    Memon HA; Park MH
    Methodist Debakey Cardiovasc J; 2017; 13(4):224-237. PubMed ID: 29744015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An official American Thoracic Society and European Respiratory Society policy statement: disparities in respiratory health.
    Schraufnagel DE; Blasi F; Kraft M; Gaga M; Finn P; Rabe KF
    Eur Respir J; 2013 Oct; 42(4):906-15. PubMed ID: 24081761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Therapeutic Paradigms and Guidelines in the Management of Pulmonary Arterial Hypertension.
    Hill NS; Cawley MJ; Heggen-Peay CL
    J Manag Care Spec Pharm; 2016 Mar; 22(3 Suppl A):S3-21. PubMed ID: 27003666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment patterns and healthcare system burden of managed care patients with suspected pulmonary arterial hypertension in the United States.
    Copher R; Cerulli A; Watkins A; Laura Monsalvo M
    J Med Econ; 2012; 15(5):947-55. PubMed ID: 22554140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival differences in pediatric pulmonary arterial hypertension: clues to a better understanding of outcome and optimal treatment strategies.
    Zijlstra WMH; Douwes JM; Rosenzweig EB; Schokker S; Krishnan U; Roofthooft MTR; Miller-Reed K; Hillege HL; Ivy DD; Berger RMF
    J Am Coll Cardiol; 2014 May; 63(20):2159-2169. PubMed ID: 24681143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An American Thoracic Society/National Heart, Lung, and Blood Institute Workshop Report: Addressing Respiratory Health Equality in the United States.
    Celedón JC; Burchard EG; Schraufnagel D; Castillo-Salgado C; Schenker M; Balmes J; Neptune E; Cummings KJ; Holguin F; Riekert KA; Wisnivesky JP; Garcia JGN; Roman J; Kittles R; Ortega VE; Redline S; Mathias R; Thomas A; Samet J; Ford JG;
    Ann Am Thorac Soc; 2017 May; 14(5):814-826. PubMed ID: 28459618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and Treatment of Pulmonary Hypertension.
    Sockrider M; Roessel L; Fagan KA; Gillespie M
    Am J Respir Crit Care Med; 2021 Mar; 203(6):P14-P15. PubMed ID: 33719932
    [No Abstract]   [Full Text] [Related]  

  • 9. Contemporary trends in the diagnosis and management of pulmonary arterial hypertension: an initiative to close the care gap.
    McLaughlin VV; Langer A; Tan M; Clements PJ; Oudiz RJ; Tapson VF; Channick RN; Rubin LJ;
    Chest; 2013 Feb; 143(2):324-332. PubMed ID: 22910999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An official American Thoracic Society policy statement: pay-for-performance in pulmonary, critical care, and sleep medicine.
    Kahn JM; Scales DC; Au DH; Carson SS; Curtis JR; Dudley RA; Iwashyna TJ; Krishnan JA; Maurer JR; Mularski R; Popovich J; Rubenfeld GD; Sinuff T; Heffner JE;
    Am J Respir Crit Care Med; 2010 Apr; 181(7):752-61. PubMed ID: 20335385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Executive summary. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.
    Hansmann G; Apitz C; Abdul-Khaliq H; Alastalo TP; Beerbaum P; Bonnet D; Dubowy KO; Gorenflo M; Hager A; Hilgendorff A; Kaestner M; Koestenberger M; Koskenvuo JW; Kozlik-Feldmann R; Kuehne T; Lammers AE; Latus H; Michel-Behnke I; Miera O; Moledina S; Muthurangu V; Pattathu J; Schranz D; Warnecke G; Zartner P
    Heart; 2016 May; 102 Suppl 2():ii86-100. PubMed ID: 27053701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bosentan in pediatric patients with pulmonary arterial hypertension.
    Beghetti M
    Curr Vasc Pharmacol; 2009 Apr; 7(2):225-33. PubMed ID: 19356006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment goals in pulmonary arterial hypertension].
    Savale L; Sitbon O
    Presse Med; 2010 Jun; 39 Suppl 1():1S33-40. PubMed ID: 20732616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire: Results of the SYMPHONY Trial.
    Chin KM; Gomberg-Maitland M; Channick RN; Cuttica MJ; Fischer A; Frantz RP; Hunsche E; Kleinman L; McConnell JW; McLaughlin VV; Miller CE; Zamanian RT; Zastrow MS; Badesch DB
    Chest; 2018 Oct; 154(4):848-861. PubMed ID: 29705220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An official American Thoracic Society/European Respiratory Society policy statement: disparities in respiratory health.
    Schraufnagel DE; Blasi F; Kraft M; Gaga M; Finn PW; Rabe KF;
    Am J Respir Crit Care Med; 2013 Oct; 188(7):865-71. PubMed ID: 24083859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report.
    Taichman DB; Ornelas J; Chung L; Klinger JR; Lewis S; Mandel J; Palevsky HI; Rich S; Sood N; Rosenzweig EB; Trow TK; Yung R; Elliott CG; Badesch DB
    Chest; 2014 Aug; 146(2):449-475. PubMed ID: 24937180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH.
    McCollister D; Shaffer S; Badesch DB; Filusch A; Hunsche E; Schüler R; Wiklund I; Peacock A;
    Respir Res; 2016 Jun; 17(1):72. PubMed ID: 27301413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An official American thoracic society statement: position statement on ATS activities for the promotion of respiratory and sleep/wake health and the care of the critically ill in the United States.
    Brown LK; Angus DC; Marin MG; Balmes JR; Barker AF; Ewart G; Halbower AC; Lutz PO; Mularski RA; Nathanson IT; Sanders MH; Stewart GL; Upson DJ;
    Am J Respir Crit Care Med; 2009 Nov; 180(10):1023-9. PubMed ID: 19897774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg. A Joint National Institutes of Health Clinical Center and Pulmonary Hypertension Association Symposium Report.
    Elinoff JM; Agarwal R; Barnett CF; Benza RL; Cuttica MJ; Gharib AM; Gray MP; Hassoun PM; Hemnes AR; Humbert M; Kolb TM; Lahm T; Leopold JA; Mathai SC; McLaughlin VV; Preston IR; Rosenzweig EB; Shlobin OA; Steen VD; Zamanian RT; Solomon MA
    Am J Respir Crit Care Med; 2018 Jul; 198(2):166-174. PubMed ID: 29425462
    [No Abstract]   [Full Text] [Related]  

  • 20. The cost-effectiveness of bosentan in the United Kingdom for patients with pulmonary arterial hypertension of WHO functional class III.
    Stevenson MD; Macdonald FC; Langley J; Hunsche E; Akehurst R
    Value Health; 2009; 12(8):1100-5. PubMed ID: 19558373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.